Standard glucocorticoid therapy ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
81	Congenital adrenal hyperplasia	2

81. Congenital adrenal hyperplasia

---

Clinical trials : 88 /  Drugs : 90 - (DrugBank : 23) / Drug target genes : 12 - Drug target pathways : 68

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03718234 (ClinicalTrials.gov)	January 1, 2019	11/10/2018	Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia	Interval Bolus Delivery of Subcutaneous Hydrocortisone Via Infusion Pump in Children With Congenital Adrenal Hyperplasia	Congenital Adrenal Hyperplasia;Hyperplasia;Adrenal Hyperplasia;Congenital Disorders;Adrenocortical Hyperfunction;Disorders of Sex Development;Urogenital Abnormalities;Genetic Diseases, Inborn;Steroid Metabolic Diseases, Inborn;Adrenal Gland Disease;Hydrocortisone	Drug: Subcutaneous hydrocortisone;Drug: Standard glucocorticoid therapy	University of Minnesota	NULL	Recruiting	4 Years	18 Years	All	8	Phase 1	United States
2	NCT02716818 (ClinicalTrials.gov)	February 22, 2016	26/2/2016	Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia	A Phase III Study of Efficacy, Safety and Tolerability of Chronocort® Compared With Standard Glucocorticoid Replacement Therapy in the Treatment of Congenital Adrenal Hyperplasia	Congenital Adrenal Hyperplasia	Drug: Chronocort®;Drug: standard glucocorticoid therapy	Diurnal Limited	NULL	Completed	18 Years	N/A	All	122	Phase 3	United States